Skip to content

Comparison on the occurrence of bleeding related events in influenza outpatients by treatment status using health insurance claims database

Comparison on the occurrence of bleeding related events in influenza outpatients by treatment status using health insurance claims database - Comparison on the occurrence of bleeding related events in influenza outpatients by treatment status using health insurance claims database

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000041568
Enrollment
1300000
Registered
2020-08-26
Start date
2020-07-13
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Influenza virus infection

Interventions

None listed

Sponsors

Shionogi & Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Patients whose first diagnosis date for influenza (Day 1) was within the enrollment period (1st Oct 2017 to 11th April 2019) 2) Patients who received some outpatient consultation (medical care or drug prescription) on Day 1. 3) Patients who were continuously registered in the database for at least 6 months before Day 1

Exclusion criteria

Exclusion criteria: 1) Patients who have another influenza diagnosis in the last 20 days before Day 1. 2) Patients who received anti-influenza drugs in the last 20 days before Day 1. 3) Patients who withdrew from the database before Day 20. 4) Patients who were hospitalized on Day 1. 5) Patients who received several anti-influenza drugs on Day 1.

Design outcomes

Primary

MeasureTime frame
Occurrence of bleeding related events

Countries

Japan

Contacts

Public ContactKanae Hara

Shionogi & Co., Ltd. Pharmacovigilance Department

kanae.hara@shionogi.co.jp+81-6-6209-6958

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026